Global Times: GT survey shows nearly 90 percent of Americans concerned about China-US ties
BEIJING, Nov. 7, 2024 /PRNewswire/ — As the most closely watched event in the “super election year,” the 2024 US presidential election is likely to have far-reaching implications for the international political and economic landscape, and has become an important window into the US
Saramonic Ultra Launched: A Pro Wireless Microphone with Timecode for Pro Creators
NEW YORK, Nov. 8, 2024 /PRNewswire/ — Saramonic launches its latest wireless lavalier microphone—Saramonic Ultra—for professional creators. With timecode, 130 dB SPL, 32-bit float onboard recording, IPX5-rated transmitters, and an external antenna, the Saramonic Ultra is packed with pro fe
Media Advisory – Prime Minister’s itinerary for Friday, November 8, 2024
OTTAWA, ON, Nov. 7, 2024 /CNW/ – Greater Vancouver Area, British Columbia The Prime Minister will make a housing announcement. A media availability will follow. Notes for media: Open coverage Media interested in participating can contact [email protected] for details. The Prime Minister wil
MasChain Expands Ecosystem with New Grant Recipient, Frac
KUALA LUMPUR, Malaysia, Nov. 7, 2024 /PRNewswire/ — Masverse is pleased to announce Frac as the latest grant recipient and onboard partner within the MasChain ecosystem. Frac has been awarded a grant of RM200,000 as part of this initiative. By joining MasChain, Frac brings extensive expertise
InxMed Presents Data regarding Potential Novel Way to Improve Therapeutic Window of ADC by Ifebemtinib and FIC ADC at 15th Annual World ADC
NANJING, China, Nov. 7, 2024 /PRNewswire/ — InxMed Co., Ltd, a clinical-stage biotechnology company developing innovative therapies against tumor-treatment resistance and metastasis, is presenting preclinical data at 15th Annual World ADC Conference in San Diego regarding ifebemtinib (ifebe
Aulisa® Medical Expands Access with New Leasing Options for Procuring Advanced Monitoring Solutions
PALO ALTO, Calif., Nov. 7, 2024 /PRNewswire/ — Aulisa® Medical USA, Inc., a leader in FDA-cleared, wearable, wireless continuous vital sign monitoring technology, proudly announces the launch of flexible leasing options for its state-of-the-art monitoring solutions. This strategic move unders
ALLEGIANT AIR TEAMSTERS VOTE TO AUTHORIZE STRIKE
Pilots Prepare to Take Action as Airline Drags Its Feet LAS VEGAS, Nov. 7, 2024 /PRNewswire/ — Allegiant Air pilots represented by Teamsters Local 2118 have voted overwhelmingly, by 97.4 percent, to authorize a strike if the carrier fails to reach a fair agreement rewarding and protecting 1,30
GoSchool: Redefining Inclusive Education for Special Learning Needs
MUMBAI, India, Nov. 8, 2024 /PRNewswire/ — GoSchool, a progressive international online school, is breaking new ground to ensure that every child, irrespective of their learning needs, has access to high-quality education. Serving students with ADHD, high-functioning autism, dyslexia, and phys
JAMA Oncology Publishes Phase 1b/2 Study Data on IASO Bio’s Equecabtagene Autoleucel (Fucaso™) in the Treatment of Relapsed/Refractory Multiple Myeloma
—— The Phase 1b/2 study FUMANBA-1 demonstrates Equecabtagene Autoleucel led to deep and durable responses in patients with R/RMM —— The data shows the overall response rate（ORR）was 96.1%，the ORR reached 98.9% among the patients without prior CAR-T therapy ——Among the 103 patients,
Ping An Health and Medtronic Form Strategic Partnership at the China International Import Expo (CIIE)
HONG KONG and SHANGHAI, Nov. 7, 2024 /PRNewswire/ — Ping An Healthcare and Technology Company Limited (“Ping An Good Doctor“, “Ping An Health”, or “the Company”, Stock Code: 1833.HK) established a strategic partnership with Medtronic (Shanghai) Management
